Impax Asset Management Group
CL icon

Impax Asset Management Group’s Colgate-Palmolive CL Stock Holding History

Impax Asset Management Group’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.44M Sell
98,895
-31,472
-24% -$2.85M 0.06% 173
2026
Q2 		$12M Sell
130,367
-77,895
-37% -$6.82M 0.08% 159
2026
Q1 		$17.8M Sell
208,262
-118,517
-36% -$10.6M 0.12% 107
2025
Q4 		$25.8M Buy
326,779
+73,814
+29% +$5.79M 0.16% 91
2025
Q3 		$20.2M Buy
252,965
+1,325
+0.5% +$113K 0.12% 100
2025
Q2 		$22.9M Buy
251,640
+11,790
+5% +$1.08M 0.13% 98
2025
Q1 		$22.5M Buy
239,850
+219,946
+1,105% +$19.7M 0.14% 103
2024
Q4 		$1.81M Buy
19,904
+1,508
+8% +$144K 0.01% 250
2024
Q3 		$1.91M Sell
18,396
-154,047
-89% -$15.7M 0.01% 255
2024
Q2 		$16.7M Sell
172,443
-370,295
-68% -$34.2M 0.07% 136
2024
Q1 		$48.9M Sell
542,738
-65,171
-11% -$5.52M 0.19% 98
2023
Q4 		$48.5M Sell
607,909
-86,870
-13% -$6.53M 0.19% 93
2023
Q3 		$49.4M Buy
694,779
+152,352
+28% +$11.4M 0.22% 93
2023
Q2 		$41.8M Buy
542,427
+509,543
+1,550% +$39.4M 0.17% 107
2023
Q1 		$2.47M Sell
32,884
-198
-0.6% -$14.7K 0.01% 226
2022
Q4 		$2.61M Buy
33,082
+18,568
+128% +$1.39M 0.01% 215
2022
Q3 		$1.02M Sell
14,514
-600
-4% -$47K 0.01% 265
2022
Q2 		$1.21M Hold
15,114
– – 0.01% 266
2022
Q1 		$1.15M Sell
15,114
-77
-0.5% -$6.1K ﹤0.01% 280
2021
Q4 		$1.3M Sell
15,191
-415
-3% -$32.4K ﹤0.01% 277
2021
Q3 		$1.18M Hold
15,606
– – ﹤0.01% 274
2021
Q2 		$1.27M Hold
15,606
– – 0.01% 269
2021
Q1 		$1.23M Buy
+15,606
New +$1.22M 0.01% 272
2019
Q4 		– Sell
-16,128
Closed -$1.19M – 281
2019
Q3 		$1.19M Buy
16,128
+1,526
+10% +$111K 0.02% 205
2019
Q2 		$1.05M Buy
14,602
+1,438
+11% +$102K 0.01% 201
2019
Q1 		$902K Sell
13,164
-165,112
-93% -$10.7M 0.01% 231
2018
Q4 		$10.6M Buy
178,276
+303
+0.2% +$19K 0.17% 103
2018
Q3 		$11.9M Buy
+177,973
New +$11.9M 0.17% 120

Other funds holding CL

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Impax Asset Management Group's CL Position: Q3 2026 in Review

Impax Asset Management Group reduced its Colgate-Palmolive (CL) stake by 24% in Q3 2026, selling an estimated $2.85M and leaving 98,895 shares worth $8.44M. The position accounts for 0.06% of the portfolio, ranked #173.

Impax Asset Management Group first reported a position in CL in Q3 2018 and has held it in 28 quarters since. The position peaked at $49.4M in Q3 2023. 1,712 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Impax Asset Management Group held 98,895 shares of Colgate-Palmolive worth $8.44M as of Q3 2026.
  • Impax Asset Management Group sold 31,472 Colgate-Palmolive shares in Q3 2026, an estimated $2.85M.
  • Colgate-Palmolive made up 0.06% of Impax Asset Management Group's portfolio in Q3 2026, its #173 holding.
  • Impax Asset Management Group first reported a position in Colgate-Palmolive in Q3 2018 and has held it in 28 quarters since.
  • Impax Asset Management Group's Colgate-Palmolive position peaked at $49.4M in Q3 2023.
  • 1,712 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Impax Asset Management Group's 13F filing for Q3 2026, filed 10 Nov 2026.